A team of scientists from Cleveland Clinic’s Lerner Research Institute, Johns Hopkins University School of Medicine and Johns Hopkins Drug Discovery has synthesized and tested a new class of gut-restricted oral therapies that shows promise in treating inflammatory bowel disease.Read More
A topical application of PALA, a chemotherapy no longer in use, improves the clearance of resistant bacteria in human skin.
Cleveland Clinic researchers are trying to speed recovery from spinal cord injury using noninvasive brain stimulation.
Cleveland Clinic researchers identify pro-inflammatory, pro-coagulant proteins and particles that are released from placental cells in preeclampsia.
New research suggests that supplementing antibiotic therapy with a butyrate-producing probiotic and prebiotic may make the gut environment unfriendly to C. diff and prevent CD infection.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Investigators found that patients with ESRD living in areas with lower residential life expectancy had significantly poorer health outcomes and reduced incidence of important processes of care compared to patients living in higher life expectancy areas.
Cisplatin and CBL0137 work synergistically to attack a combination of three different cellular pathways that contribute to chemotherapy resistance.
A WASP/WAVE actin-cytoskeleton remodeling protein plays a major role in chemoresistance in triple-negative breast cancers.
Researchers will use Microsoft’s HoloLens and an application for the mixed reality technology to visualize surgery in true 3-D.
For the first time, research suggests that Akt3 protects against diet-related obesity in a preclinical model by suppressing a mechanism of adipogenesis. Eugene Podrez, MD, PhD, explains.
Cleveland Clinic researchers have pinpointed the transcription factor that regulates the differentiation of CD4+ helper cells into a subset that has anti-tumor effects.